Not found

Dan Peer, PhD

Full Affiliate Member, Research Institute
Houston Methodist


Publications

Resveratrol enhances mrna and sirna lipid nanoparticles primary CLL cell transfection
Kon, E, Hazan-Halevy, I, Rosenblum, D, Cohen, N, Chatterjee, S, Veiga, N, Raanani, P, Bairey, O, Benjamini, O, Nagler, A & Peer, D 2020, Pharmaceutics, vol. 12, no. 6, 520, pp. 1-14. https://doi.org/10.3390/pharmaceutics12060520

Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner
Van de Vyver, T, Bogaert, B, De Backer, L, Joris, F, Guagliardo, R, Van Hoeck, J, Merckx, P, Van Calenbergh, S, Ramishetti, S, Peer, D, Remaut, K, De Smedt, SC & Raemdonck, K 2020, , ACS Nano, vol. 14, no. 4, pp. 4774-4791. https://doi.org/10.1021/acsnano.0c00666

A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
Ramishetti, S, Hazan-Halevy, I, Palakuri, R, Chatterjee, S, Naidu Gonna, S, Dammes, N, Freilich, I, Kolik Shmuel, L, Danino, D & Peer, D 2020, Advanced Materials, vol. 32, no. 12, 1906128. https://doi.org/10.1002/adma.201906128

An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeutics
Singh, MS, Goldsmith, M, Thakur, K, Chatterjee, S, Landesman-Milo, D, Levy, T, Kunz-Schughart, LA, Barenholz, Y & Peer, D 2020, Nanoscale, vol. 12, no. 3, pp. 1894-1903. https://doi.org/10.1039/c9nr09572a

Monoclonal antibody-based molecular imaging strategies and theranostic opportunities
Dammes, N & Peer, D 2020, Theranostics, vol. 10, no. 2, pp. 938-955. https://doi.org/10.7150/thno.37443

Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
Veiga, N, Diesendruck, Y & Peer, D 2020, Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2020.04.002

Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy
Gao, M, Deng, J, Liu, F, Fan, A, Wang, Y, Wu, H, Ding, D, Kong, D, Wang, Z, Peer, D & Zhao, Y 2019, Biomaterials, vol. 223, 119486. https://doi.org/10.1016/j.biomaterials.2019.119486

Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target
Veiga, N, Goldsmith, M, Diesendruck, Y, Ramishetti, S, Rosenblum, D, Elinav, E, Behlke, MA, Benhar, I & Peer, D 2019, Journal of Controlled Release, vol. 313, pp. 33-41. https://doi.org/10.1016/j.jconrel.2019.10.001

Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (Nature Nanotechnology, (2019), 14, 7, (629-635), 10.1038/s41565-019-0496-9)
Leong, HS, Butler, KS, Brinker, CJ, Azzawi, M, Conlan, S, Dufès, C, Owen, A, Rannard, S, Scott, C, Chen, C, Dobrovolskaia, MA, Kozlov, SV, Prina-Mello, A, Schmid, R, Wick, P, Caputo, F, Boisseau, P, Crist, RM, McNeil, SE, Fadeel, B, Tran, L, Hansen, SF, Hartmann, NB, Clausen, LPW, Skjolding, LM, Baun, A, Ågerstrand, M, Gu, Z, Lamprou, DA, Hoskins, C, Huang, L, Song, W, Cao, H, Liu, X, Jandt, KD, Jiang, W, Kim, BYS, Wheeler, KE, Chetwynd, AJ, Lynch, I, Moghimi, SM, Nel, A, Xia, T, Weiss, PS, Sarmento, B, das Neves, J, Santos, HA, Santos, L, Mitragotri, S, Little, S, Peer, D, Amiji, MM, Alonso, MJ, Petri-Fink, A, Balog, S, Lee, A, Drasler, B, Rothen-Rutishauser, B, Wilhelm, S, Acar, H, Harrison, RG, Mao, C, Mukherjee, P, Ramesh, R, McNally, LR, Busatto, S, Wolfram, J, Bergese, P, Ferrari, M, Fang, RH, Zhang, L, Zheng, J, Peng, C, Du, B, Yu, M, Charron, DM, Zheng, G & Pastore, C 2019, Nature Nanotechnology, vol. 14, no. 9. https://doi.org/10.1038/s41565-019-0538-3

Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (Nature Nanotechnology, (2019), 14, 7, (629-635), 10.1038/s41565-019-0496-9)
Leong, HS, Butler, KS, Brinker, CJ, Azzawi, M, Conlan, S, Dufès, C, Owen, A, Rannard, S, Scott, C, Chen, C, Dobrovolskaia, MA, Kozlov, SV, Prina-Mello, A, Schmid, R, Wick, P, Caputo, F, Boisseau, P, Crist, RM, McNeil, SE, Fadeel, B, Tran, L, Hansen, SF, Hartmann, NB, Clausen, LPW, Skjolding, LM, Baun, A, Ågerstrand, M, Gu, Z, Lamprou, DA, Hoskins, C, Huang, L, Song, W, Cao, H, Liu, X, Jandt, KD, Jiang, W, Kim, BYS, Wheeler, KE, Chetwynd, AJ, Lynch, I, Moghimi, SM, Nel, A, Xia, T, Weiss, PS, Sarmento, B, Neves, JD, Santos, HA, Santos, L, Mitragotri, S, Little, S, Peer, D, Amiji, MM, Alonso, MJ, Petri-Fink, A, Balog, S, Lee, A, Drasler, B, Rothen-Rutishauser, B, Wilhelm, S, Acar, H, Harrison, RG, Mao, C, Mukherjee, P, Ramesh, R, McNally, LR, Busatto, S, Wolfram, J, Bergese, P, Ferrari, M, Fang, RH, Zhang, L, Zheng, J, Peng, C, Du, B, Yu, M, Charron, DM, Zheng, G & Pastore, C 2019, Nature Nanotechnology, vol. 14, no. 8. https://doi.org/10.1038/s41565-019-0523-x

Therapeutic mRNA delivery to leukocytes
Granot-Matok, Y, Kon, E, Dammes, N, Mechtinger, G & Peer, D 2019, Journal of Controlled Release, vol. 305, pp. 165-175. https://doi.org/10.1016/j.jconrel.2019.05.032

On the issue of transparency and reproducibility in nanomedicine
Leong, HS, Butler, KS, Brinker, CJ, Azzawi, M, Conlan, S, Dufés, C, Owen, A, Rannard, S, Scott, C, Chen, C, Dobrovolskaia, MA, Kozlov, SV, Prina-Mello, A, Schmid, R, Wick, P, Caputo, F, Boisseau, P, Crist, RM, McNeil, SE, Fadeel, B, Tran, L, Hansen, SF, Hartmann, NB, Clausen, LPW, Skjolding, LM, Baun, A, Ågerstrand, M, Gu, Z, Lamprou, DA, Hoskins, C, Huang, L, Song, W, Cao, H, Liu, X, Jandt, KD, Jiang, W, Kim, BYS, Wheeler, KE, Chetwynd, AJ, Lynch, I, Moghimi, SM, Nel, A, Xia, T, Weiss, PS, Sarmento, B, das Neves, J, Santos, HA, Santos, L, Mitragotri, S, Little, S, Peer, D, Amiji, MM, Alonso, MJ, Petri-Fink, A, Balog, S, Lee, A, Drasler, B, Rothen-Rutishauser, B, Wilhelm, S, Acar, H, Harrison, RG, Mao, C, Mukherjee, P, Ramesh, R, McNally, LR, Busatto, S, Wolfram, J, Bergese, P, Ferrari, M, Fang, RH, Zhang, L, Zheng, J, Peng, C, Du, B, Yu, M, Charron, DM, Zheng, G & Pastore, C 2019, Nature Nanotechnology, vol. 14, no. 7, pp. 629-635. https://doi.org/10.1038/s41565-019-0496-9

A tissue chamber chip for assessing nanoparticle mobility in the extravascular space
Lusi, V, Moore, TL, Laurino, F, Coclite, A, Perreira, R, Ferreira, M, Rizzuti, I, Palomba, R, Zunino, P, Duocastella, M, Mizrahy, S, Peer, D & Decuzzi, P 2019, Biomedical Microdevices, vol. 21, no. 2, 41. https://doi.org/10.1007/s10544-019-0398-5

Challenges in IBD Research: Novel Technologies
Dhyani, M, Joshi, N, Bemelman, WA, Gee, MS, Yajnik, V, DHoore, A, Traverso, G, Donowitz, M, Mostoslavsky, G, Lu, TK, Lineberry, N, Niessen, HG, Peer, D, Braun, J, Delaney, CP, Dubinsky, MC, Guillory, AN, Pereira, M, Shtraizent, N, Honig, G, Polk, DB, Hurtado-Lorenzo, A, Karp, JM & Michelassi, F 2019, Inflammatory bowel diseases, vol. 25, no. Supplement_2, pp. S24-S30. https://doi.org/10.1093/ibd/izz077

Reprogramming the lymphocyte axis for advanced immunotherapy
Moghimi, SM & Peer, D 2019, Advanced Drug Delivery Reviews, vol. 141, pp. 1-2. https://doi.org/10.1016/j.addr.2019.07.001

Systemic modulation of lymphocyte subsets using siRNAs delivered via targeted lipid nanoparticles
Hazan-Halevy, I, Rosenblum, D, Ramishetti, S & Peer, D 2019, . in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1974, Humana Press, pp. 151-159. https://doi.org/10.1007/978-1-4939-9220-1_11

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
Veiga, N, Goldsmith, M, Granot, Y, Rosenblum, D, Dammes, N, Kedmi, R, Ramishetti, S & Peer, D 2018, , Nature Communications, vol. 9, no. 1, 4493. https://doi.org/10.1038/s41467-018-06936-1

Quantitative analysis of recombinant glucocerebrosidase brain delivery via lipid nanoparticles
Goldsmith, M, Abramovitz, L, Braunstein, H, Horowitz, M & Peer, D 2018, Nano Futures, vol. 2, no. 4, 045003. https://doi.org/10.1088/2399-1984/aadd34

Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D, Joshi, N, Tao, W, Karp, JM & Peer, D 2018, , Nature Communications, vol. 9, no. 1, 1410. https://doi.org/10.1038/s41467-018-03705-y

Gene Silencing in the Right Place at the Right Time
Guktin, A & Peer, D 2018, , Molecular Therapy, vol. 26, no. 11, pp. 2539-2541. https://doi.org/10.1016/j.ymthe.2018.10.005